Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?

To: bysfbay who wrote (491)	11/7/1997 11:24:00 AM
From: Brian Pastor	Respond to of 998

WHat I'd really like to see is some hard core financial analysis from someone who is knowledgeable about the books regarding how dependent the company is on this drug -- a scenerio that if approval is not forthcoming, what might happen to share price and long term prospects and vice-versa. I am not going to do it becuase I am not invested. I have not seen any of this on this thread. All I have heard so far is worthless speculation related to company's cash position which is tremendously misleading and worthless as a measure of a company. You cannot take one piece of a B/S and make a judgment about a company's worth, that is completely moronic and worse yet, may acutalluy encourage someone who does not have any knowledge to invest.